What you'll learn

  • Identify current and emerging approaches to early detection, screening, and prevention of hereditary breast, ovarian, pancreatic, and prostate cancers associated with mutations in the BRCA pathway. 

  • Recognize and analyze the latest clinical and translational discoveries in the treatment of breast, ovarian, pancreatic, and prostate cancers associated with hereditary or acquired mutations in BRCA1/2 and related genes. 

  • Discuss current ethical, legal, social as well as diversity and inclusion issues related to carriers of BRCA1/2 and related genes. 

Course description

Who Should Attend

  • Specialty Physicians
  • Researchers
  • Clinicians 
  • Other

You may also like

Blended

This Harvard Medical School one-year, application-based certificate program equips surgeons with the skills, strategies and confidence to take on greater leadership roles. 

Price
$17,900 - $18,900
Registration Deadline
Starts Apr 8
Online

Learn foundational concepts in physiology and see how the material is used in taking care of patients.

Price
$800 - $995
Registration Deadline